Pharma Industry

Corona Vaccine: Vaccine development takes years. But one for the pandemic by early 2021? Here’s a reality check.

A laboratory technician with a dose of a Covid-19 vaccine candidate, ready for trial on monkeys, at the National Primate Research Center of Thailand at Chulalongkorn University, in Saraburi on May 23, 2020.


Around 120 Covid-19 vaccines are under research across the world. Besides being a long-drawn process, the lack of convincing data and the fickle nature of the novel coronavirus would call for a tempered expectation of a vaccine. But some scientists have promised that millions of doses will be available by early 2021. So, what’s fuelling such optimism?

The self-effacing bioscience labs on the sprawling campus of the Indian Institute of Technology Guwahati belie the battle being waged inside. A team of scientists helmed by Sachin Kumar, a doctorate in molecular virology from the University of Maryland, the US, is hard at work to develop a vaccine against the wily SARS-CoV-2 virus. In the early days of the pandemic, ET Prime had outlined some of the challenges of developing a vaccine and

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

Source link